Kate H. Kraft

2 weeks ago | urologytimes.com | Kate H. Kraft |Benjamin P. Saylor

In a recent interview with Urology Times®, Kate H. Kraft, MD, MHPE, FACS, FAAP, discussed a recent study regarding the use of tamsulosin (Flomax) in pediatric patients undergoing ureteroscopy.1 During the interview, she was asked about the implications of reducing repeat anesthetic exposures in children.

3 weeks ago | urologytimes.com | Kate H. Kraft |Benjamin P. Saylor

In a recent study, investigators evaluated the use of tamsulosin (Flomax) in pediatric patients undergoing ureteroscopy.1 They reported that patients who received tamsulosin had an 87% chance of having a successful URS procedure, according to senior author Kate H. Kraft, MD, MHPE, FACS, FAAP. The study findings indicate a significant age and body mass index difference between the tamsulosin and the no-tamsulosin groups.

1 month ago | urologytimes.com | Kate H. Kraft |Benjamin P. Saylor

Use of preoperative tamsulosin (Flomax) in pediatric patients undergoing ureteroscopy appears to facilitate ureteroscopic access in this patient population, according to a recent study.1In an interview with Urology Times®, senior author Kate H. Kraft, MD, MHPE, FACS, FAAP, described the background for the study. “This study has been a long time in the making.